| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 151004-94-3 | (S)-3,4-Dihydro-1,2(1H)-isoquinolinedicarboxylic acid 2-(1,1-dimethylethyl) ester | C15H19NO4 |
| 151004-96-5 | (R)-2-(tert-Butoxycarbonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid | C15H19NO4 |
| 151009-85-7 | N-Biotinyl-L-cysteine | C13H21N3O4S2 |
| 151012-17-8 | N6-[[(2-Chlorophenyl)methoxy]carbonyl]-N2-[(1,1-dimethylethoxy)carbonyl]-N2-methyl-L-lysine | C20H29ClN2O6 |
| 151012-31-6 | 1-(4-Bromobenzyl)-2-butyl-4-chloro-1H-imidazole-5-methanol | C15H18BrClN2O |
| 151038-94-7 | epsilon-Maleimidocaproyl hydrazide mono(trifluoroacetate) | C10H15N3O3.C2HF3O2 |
| 151038-96-9 | INNO-206 | C37H42N4O13 |
| 151049-87-5 | 3-Bromo-1-methyl-1H-pyrazole | C4H5BrN2 |
| 151059-43-7 | 2-Phenylethylamine Hydroiodide | C8H12IN |
| 151061-28-8 | Pravastatin EP Impurity F | C18H28O6 .Na |
| 151062-55-4 | 2-Methyl-D-cysteine hydrochloride | C4H9NO2S.HCl |
| 151077-62-2 | 2,5-Dihydro-2,5-dioxo-N-[3-[3-(trifluoromethyl)-3H-diazirin-3-yl]phenyl]-1H-pyrrole-1-butanamide | C16H13F3N4O3 |
| 151096-09-2 | Moxifloxacin | C21H24FN3O4 |
| 151096-96-7 | 4-(Phenylmethyl)-1-oxa-4,9-diazaspiro[5.5]undecan-3-one | C15H20N2O2 |
| 151096-97-8 | 4-(Phenylmethyl)-1-oxa-4,9-diazaspiro[5.5]undecane | C15H22N2O |
| 151098-14-5 | 5-(4-Methoxyphenyl)-[1,2,4]oxadiazole-3-carboxylic acid ethyl ester | C12H12N2O4 |
| 151103-08-1 | 4-Difluoromethoxy-3-hydroxybenzaldehyde | C8H6F2O3 |
| 151103-09-2 | 4-(Difluoromethoxy)-3-(cyclopropylmethoxy)benzaldehyde | C12H12F2O3 |
| 151121-39-0 | 8-(6-Hydroperoxy-3,7-dimethyl-2,7-octadienyloxy)psoralen | C21H22O6 |
| 151126-32-8 | Pramlintide | C171H267N51O53S2 |
| 151131-88-3 | 2-Bromo-6-diphenylphosphinopyridine | C17H13BrNP |
| 151132-82-0 | N-Cbz-N'-Fmoc-L-2,4-Diaminobutyric acid | C27H26N2O6 |
| 151132-95-5 | 9-[5-O-[Bis(4-methoxyphenyl)phenylmethyl]-3-O-[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-2-O-[(1,1-dimethylethyl)dimethylsilyl]-beta-D-ribofuranosyl]-9H-purine | C46H61N6O7PSi |
| 151135-82-9 | Kazonol C | C25H28O4 |
| 151151-30-3 | Isoleucinyl-glycinyl-leucinyl-methionine | C19H36N4O5S |
| 151151-32-5 | 2'-Deoxycytidine-5'-diphosphate trisodium salt | C9H12N3Na3O10P2 |
| 151169-67-4 | 4-Chloro-3-nitrophenylboronic acid | C6H5BClNO4 |
| 151169-74-3 | 2,3-Dichlorophenylboronic acid | C6H5BCl2O2 |
| 151169-75-4 | 3,4-Dichlorophenylboronic acid | C6H5BCl2O2 |
| 151171-11-8 | N-tert-Butoxycarbonyl-L-isovaline | C10H19NO4 |
| 151200-48-5 | Borapetoside D | C33H46O16 |
| 151200-49-6 | Borapetoside E | C27H36O11 |
| 151200-50-9 | Borapetoside F | C27H34O11 |
| 151200-92-9 | Poricoic acid AM | C32H48O5 |
| 151213-15-9 | 8-Desmethoxy-8-fluoromoxifloxacin | C20H21F2N3O3 |
| 151213-40-0 | (S,S)-2,8-Diazabicyclo[4.3.0]nonane | C7H14N2 |
| 151213-42-2 | (1R,6R)-2,8-Diazabicyclo[4,3,0]nonane | C7H14N2 |
| 151213-43-3 | (4aR,7aR)-Octahydro-6-(phenylmethyl)-1H-pyrrolo[3,4-b]pyridine | C14H20N2 |
| 151250-15-6 | Morphine 3-beta-D-glucuronide triacetate methyl ester | C30H35NO12 |
| 151250-76-9 | (S)-9-Fluoro-2,3-dihydro-3-methyl-10-[[2-(methylamino)ethyl]amino]-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid | C16H18FN3O4 |
| 151252-98-1 | 2,3-Dihydro-N-benzyl-1H-inden-1-amine | C16H17N |
| 151257-01-1 | 2-Butyl-4-spirocyclopentane-2-imidazolin-5-one hydrochloride | C11H18N2O.HCl;C11H19ClN2O |
| 151258-20-7 | 1-[(4-Bromomethylphenyl)sulfonyl]pyrrolidine | C11H14BrNO2S |
| 151262-93-0 | 2-Methyl-N-[2-nitro-5-(trifluoromethyl)phenyl]propanamide | C11H11F3N2O3 |
| 151265-33-7 | (9b,11b,16a)-9,11-Epoxy-21-hydroxy-16-methylpregna-1,4-diene-3,20-dione | C22H28O4 |
| 151266-23-8 / 570409-85-7 | 4-Amino-3-iodopyrazolo[3,4-d]pyrimidine | C5H4IN5 |
| 151271-53-3 | 2'-(2-Hydroxyphenyl)-[2,4'-bibenzoxazole]-4-carboxylic acid methyl ester | C22H14N2O5 |
| 151294-93-8 | tert-Butyl 2-(tert-butoxycarbonylamino)hex-5-enoate | C15H27NO4 |
| 151319-34-5 | Zaleplon | C17H15N5O |
| 151334-06-4 | 3-O-p-Coumaroyloleanolic acid | C39H54O5 |